SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership.

van der Feltz-Cornelis, CM; Sweetman, J; Edwards, M; Gall, N; Gilligan, J; Hayle, S; Kaul, A; Moriarty, AS; Perros, P; Sampford, J; et al. van der Feltz-Cornelis, CM; Sweetman, J; Edwards, M; Gall, N; Gilligan, J; Hayle, S; Kaul, A; Moriarty, AS; Perros, P; Sampford, J; Smith, N; Elfeddali, I; Varley, D; Gower, J (2022) Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership. BMJ Open, 12 (7). e061263. ISSN 2044-6055 https://doi.org/10.1136/bmjopen-2022-061263
SGUL Authors: Edwards, Mark John James

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

OBJECTIVES: This study establishes research priorities for medically not yet explained symptoms (MNYES), also known as persistent physical symptoms or medically unexplained symptoms, from the perspective of patients, caregivers and clinicians, in a priority setting partnership (PSP) following the James Lind Alliance (JLA) approach. Research into such symptoms in general has been poorly funded over the years and so far has been primarily researcher-led with minimal input from patients, caregivers and clinicians; and sometimes has been controversial. DESIGN: JLA PSP method. The PSP termed these symptoms MNYES. METHODS: The study was conducted according to the JLA's detailed methodology for conducting priority setting exercises. It involved five key stages: defining the appropriate term for the conditions under study by the PSP Steering Group; gathering questions on MNYES from patients, caregivers and clinicians in a publicly accessible survey; checking these research questions against existing evidence; interim prioritisation in a second survey; and a final multi-stakeholder consensus meeting to determine the top 10 unanswered research questions using the modified nominal group methodology. RESULTS: Over 700 responses from UK patients, caregivers and clinicians were identified in the two surveys and charities contributed from a broad range of medical specialties and primary care. The final top 10 unanswered research questions cover, among others: treatment strategies, personalisation of treatment, collaborative care pathways, training for clinicians and outcomes that matter to patients. INTERPRETATION: The top 10 unanswered research questions are expected to generate much needed, relevant and impactful research into MNYES.

Item Type: Article
Additional Information: © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Keywords: Adult cardiology, Adult neurology, Adult psychiatry, Functional bowel disorders, PRIMARY CARE, Rheumatology, Caregivers, Consensus, Humans, Research Design, Research Personnel, Surveys and Questionnaires, Humans, Consensus, Research Design, Caregivers, Research Personnel, Surveys and Questionnaires, 1103 Clinical Sciences, 1117 Public Health and Health Services, 1199 Other Medical and Health Sciences
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: BMJ Open
ISSN: 2044-6055
Language: eng
Dates:
DateEvent
1 July 2022Published
14 June 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
204829Wellcome Trusthttp://dx.doi.org/10.13039/100004440
PubMed ID: 35777869
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114559
Publisher's version: https://doi.org/10.1136/bmjopen-2022-061263

Actions (login required)

Edit Item Edit Item